CluePoints has appointed Martin Magazzolo as Chief Commercial Officer, strengthening its executive leadership team as the company enters its next phase of commercial growth and category leadership.

CluePoints is helping redefine how modern clinical trials are managed through its Risk-Based Quality Management (RBQM) platform. Combining advanced analytics, AI-enabled workflow automation and statistical monitoring, the company enables pharmaceutical sponsors and CROs to identify quality risks earlier, improve oversight and make faster, more informed decisions across increasingly complex clinical studies.

Martin joins with more than three decades of executive leadership experience spanning enterprise software, healthcare technology and life sciences. Most recently, he led Strategy & Growth for Electronic Defence Systems at Honeywell Aerospace, following four years as Chief Commercial Officer at Honeywell Life Sciences. In that role, he led the global commercial strategy for its Connected Life Sciences business, overseeing sales, customer success, strategic partnerships and go-to-market execution. Earlier in his career, Martin held senior leadership positions at IQVIA, LexisNexis Risk Solutions and CSC, building and scaling global commercial organisations serving pharmaceutical and biotechnology customers.

His appointment reflects CluePoints' ambition to further professionalise its commercial organisation while accelerating enterprise growth.

This search assignment was led by Andrew Banks, Managing Partner and Eon de Quelen, Partner, with support from William Batt, Senior Associate at Faraday Partners, in collaboration with Andrew Cooper, CEO of CluePoints;  their wider leadership team (Sinead Godkin, Richard Young, Amit Patel); alongside Eran Broshy, Board Chairman of CluePoints and their investors Mark Braganza and Kirk Lepke at EQT.

About CluePoints

CluePoints is a clinical trial technology company helping pharmaceutical sponsors and CROs improve quality, compliance and operational oversight through Risk-Based Quality Management (RBQM). Founded in Belgium in 2012, the company combines advanced statistical analytics, AI-enabled workflow automation and cloud-based software to help customers identify risk earlier, improve trial quality and accelerate clinical development. 

CluePoints is backed by EQT (Mark Braganza and Kirk Lepke) and Summit Partners (Thomas Tarnowski).

About Faraday Partners

Faraday Partners is a global executive search firm supporting the most valuable companies in tech and their investors from early conviction to industry impact. We specialise in senior leadership appointments across all facets of leadership, helping organisations secure transformative leaders who scale businesses, drive innovation, and create long-term enterprise value.